Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic flexibility secures skeletal progenitor function upon reduced glycolysis driven by PFKFB3 loss.

Bone·2026
Same author

Mitochondria-targeted OXPHOS inhibition enhances radiotherapy efficacy by disrupting mitochondrial function.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Head-to-head comparison of nuclear imaging approaches to quantify tumor CD8<sup>+</sup> T-cell infiltration.

Immunotherapy advances·2026
Same author

Sialic acid <i>cis</i>-ligand dynamics modulate Siglec-7 and -9 function and affect Siglec-7/9 co-blockade to potentiate natural killer cell anti-tumor activity.

Oncoimmunology·2026
Same author

In-vivo analysis of neuroblastoma targeting potential of aGD2-SIRPα fusion antibodies for local CD47 blockade.

Molecular cancer therapeutics·2026
Same author

Decoding the immune-tumor synapse for data-driven design of next-generation immunotherapies.

Trends in immunology·2026

Related Experiment Video

Updated: May 4, 2026

Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
13:34

Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors

Published on: March 17, 2014

10.4K

Vitamin D controls murine and human plasmacytoid dendritic cell function.

Nina Karthaus1, Annemiek B van Spriel1, Maaike W G Looman1

  • 1Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.

The Journal of Investigative Dermatology
|December 20, 2013
PubMed
Summary

Vitamin D (VitD) signaling inhibits plasmacytoid dendritic cells (pDCs), crucial in psoriasis. This discovery opens avenues for new VitD-based therapies for inflammatory skin conditions.

More Related Videos

Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro
06:12

Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro

Published on: March 7, 2022

3.0K
Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
09:51

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

Published on: May 18, 2018

10.3K

Related Experiment Videos

Last Updated: May 4, 2026

Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
13:34

Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors

Published on: March 17, 2014

10.4K
Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro
06:12

Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro

Published on: March 7, 2022

3.0K
Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
09:51

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

Published on: May 18, 2018

10.3K

Area of Science:

  • Immunology
  • Dermatology
  • Endocrinology

Background:

  • Topical calcipotriol, a vitamin D (VitD) analog, effectively treats psoriasis but its immune effects are unclear.
  • Plasmacytoid dendritic cells (pDCs) infiltrate psoriatic skin and drive disease pathogenesis.
  • Conventional dendritic cells (cDCs) are known to be modulated by VitD towards tolerogenic responses.

Purpose of the Study:

  • To investigate the role and effects of VitD signaling in pDCs in the context of psoriasis.
  • To determine if VitD can modulate pDC function and their interaction with T-cells.

Main Methods:

  • Analysis of VitD receptor (VDR) pathway components in murine and human pDCs.
  • Assessment of VitD's impact on pDC-mediated T-cell proliferation and IFNγ secretion.
  • Investigating the dependence of VitD's inhibitory effects on VDR expression.

Main Results:

  • pDCs express key VDR pathway proteins, including metabolizing enzymes Cyp27B1 and Cyp24A1, with active VDR.
  • VitD significantly impairs the ability of pDCs to stimulate T-cell proliferation and IFNγ production.
  • These inhibitory effects of VitD on pDCs are dependent on VDR expression.

Conclusions:

  • VitD signaling acts as a natural inhibitory mechanism on both cDCs and pDCs.
  • This study supports the development of VitD-based therapeutic strategies for psoriasis and other inflammatory skin diseases.